Pharmacogenomics and clopidogrel: irrational exuberance?
about
Stroke genetics: prospects for personalized medicineGenotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommendedClopidogrel: a case for indication-specific pharmacogenetics.Personalised medicine: not just in our genes.Pharmacogenetics and cardiovascular disease--implications for personalized medicineAdvances in our understanding of "resistance" to antiplatelet agents for prevention of ischemic strokeFrom hot hands to declining effects: the risks of small numbers.Advances in the monitoring of anti-P2Y12 therapy.Dual antiplatelet therapy dilemmas: duration and choice of antiplatelets in acute coronary syndromes.The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.Publishing genomic studies: walking the fine line.Routine genotyping of patients on clopidogrel: Why the resistance?Analysis of CYP2D6 genotype and response to tetrabenazine.Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients.
P2860
Q27006885-783A928B-C88B-4F6B-AFA0-FC2B0DC23AB4Q33365061-B1355A36-D95B-4060-9D2A-6C2108D49D2AQ33923341-38DB8F92-6A8D-4332-AE78-ECF42A301F9BQ34990721-011414A6-5159-4534-9AB8-5E719C58D8D9Q36055186-6F11981C-5640-450D-A2D0-E639D5B5F69EQ36396620-66B6F52B-C403-408A-B9AE-5B711A5E3A4BQ36974672-A64F2474-6301-4236-88C9-7C53C079AFB0Q37051838-5C3865B3-C12B-403B-A364-C75CE812B1E3Q37151993-588674B9-A169-4724-A34D-C4E07B44EB26Q38037121-F04B4297-5520-464E-BA24-5D56F3DA6C60Q38137724-F73A5C91-E43D-4D54-8384-BF08E2858F93Q38838327-552A587E-AABD-441B-B48A-56FC352CE7BEQ42348094-FEBFCCAD-CE1E-4A55-AF41-C2A7C39A4175Q42414159-400B8337-8646-4F2F-A701-43B20174FA40Q43478633-306F8DB4-B924-4656-B82E-6DBC0AD2A26FQ50940254-B4EB36F1-7AEF-4B26-9831-AF308CBF60FB
P2860
Pharmacogenomics and clopidogrel: irrational exuberance?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pharmacogenomics and clopidogrel: irrational exuberance?
@en
Pharmacogenomics and clopidogrel: irrational exuberance?
@nl
type
label
Pharmacogenomics and clopidogrel: irrational exuberance?
@en
Pharmacogenomics and clopidogrel: irrational exuberance?
@nl
prefLabel
Pharmacogenomics and clopidogrel: irrational exuberance?
@en
Pharmacogenomics and clopidogrel: irrational exuberance?
@nl
P356
P1476
Pharmacogenomics and clopidogrel: irrational exuberance?
@en
P2093
Steven E Nissen
P304
P356
10.1001/JAMA.2011.1865
P407
P577
2011-12-01T00:00:00Z